Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Counting Market

Cell Counting Market Share

Report ID: GMI8496
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Cell Counting Market Share

Key players in the industry are driving innovation through R&D efforts to gain competitive edges. They are also continuing to shape the industry landscape by fostering competition and advancing technology to meet the evolving customer needs.

Cell Counting Market Companies

Prominent players operating in the cell counting industry are as mentioned below:

Abbott Laboratories
Agilent Technologies, Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Biotek Instruments, Inc.ChemoMetec A/S
DeNovix
Merck KGaA
NanoEnTek Inc
Olympus Corporation
Sysmex Corporation
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Cell counting market size was valued at over USD 11.6 billion in 2023 and is expected to exceed USD 20.6 by 2032 driven by the rising incidence of chronic diseases such as HIV, measles, diphtheria, cancer, and blood disorders.

The consumables and reagents segment is slated to depict 6.7% CAGR from 2024-2032 as they are essential in facilitating accurate and efficient cell counting processes.

North America cell counting industry size is expected to surpass USD 7.7 billion by 2032 due to the rising investments in healthcare infrastructure and escalating R&D activities.

Prominent cell counting companies include Abbott Laboratories, Agilent Technologies, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Biote, Instruments, Inc., ChemoMetec A/S, DeNovix, Merck KGaA, NanoEnTek Inc, Olympus Corporation, Sysmex Corporation, and Thermo Fisher Scientific Inc.